Article Details
Retrieved on: 2021-04-16 20:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The stock closed yesterday at $26.55 per share. Celcuity secured a worldwide, exclusive license to develop and commercialize Pfizer's gedatolisib, a ...
Article found on: tcbmag.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here